Company news

Zomedica Corp. (OTC:ZOMDF) news

Zomedica Corp. news releases on 6ix. Latest, May 13, 2025: Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave…

View Zomedica Corp. →

Press releases — page 2

Zomedica Launches Groundbreaking Equine Asthma Clinical Registry Featuring PulseVet(R) Shock Wave Therapy

May 13, 2025

Zomedica to Report First Quarter 2025 Financial Results with a Business Update on Thursday, May 15, 2025 at 4:30 pm ET

May 9, 2025

Sidoti Events, LLC's Virtual March Small-Cap Conference

March 17, 2025

Zomedica Reports Record Revenue of $7.9 Million for the Fourth Quarter and $27.3 Million for the Full Year 2024; 70% Gross Margin, and $71 Million in Liquidity to Support Growth

March 12, 2025

OTC Markets Group Welcomes New OTCQB Companies – March 10

March 10, 2025

Zomedica Corp. Announces Transition to OTCQB Venture Market

March 3, 2025

Zomedica to Report Fourth Quarter and Full Year 2024 Financial Results with a Business Update on March 13th at 4:30 p.m. ET

February 25, 2025

Zomedica to Build Direct Sales Force for TRUFORMA® Platform

April 15, 2021

Zomedica Announces First Commercial Sale of Its Truforma® Platform

March 16, 2021

Zomedica Retires Preferred Shares

March 8, 2021

Zomedica Corp. Announces Year End 2020 Financial Results

February 26, 2021

Zomedica Corp. Announces Full Exercise of Over-Allotment Option by Underwriter

February 16, 2021

Zomedica Corp. Announces Closing of $173.5 Million Bought Deal

February 11, 2021

Zomedica Corp. Announces $25.0 Million Bought Deal Offering of Common Shares

February 8, 2021

Zomedica Corp. Increases Previously Announced Bought Deal Offering of Common Shares to $173.5 Million

February 7, 2021

Zomedica Signs TRUFORMA™ Distribution Agreement With Miller Veterinary Supply

January 25, 2021

Zomedica CEO Issues Shareholder Letter as TRUFORMA™ Nears Commercialization

January 18, 2021

Zomedica Appoints Robert Cohen CEO as Company Nears Commercialization of TRUFORMA™

January 4, 2021

Zomedica to Remain Domiciled in Canada

December 15, 2020

Zomedica Sets March 30, 2021 as Expected Commercialization Date for TRUFORMA™

November 13, 2020

Zomedica Announces Third Quarter 2020 Financial Results

November 12, 2020

← Newer